Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ITGB3 | P05106 | 1/20 | 0.60 |
| ▸ | ITGA2B | P08514 | 1/20 | 0.60 |
| ▸ | FFAR1 | O14842 | 3/20 | 0.59 |
| ▸ | FAAH | O00519 | 7/20 | 0.50 |
| ▸ | RXRA | P19793 | 2/20 | 0.50 |
| ▸ | RXRB | P28702 | 2/20 | 0.50 |
| ▸ | RXRG | P48443 | 2/20 | 0.50 |
| ▸ | HRH3 | Q9Y5N1 | 3/20 | 0.49 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.49 |
| ▸ | HRH1 | P35367 | 1/20 | 0.49 |
| ▸ | MEN1 | O00255 | 1/20 | 0.49 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.49 |
| ▸ | MAOA | P21397 | 2/20 | 0.48 |
| ▸ | MAOB | P27338 | 2/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12471689 | 0.85 | HRH3 (0.52) | FAAHHRH3CYP2D6HRH1MAOA | |
| SCHEMBL3450818 | 0.83 | ITGB3 (0.72) | ITGB3ITGA2BFFAR1FAAHRXRA | |
| SCHEMBL12471199 | 0.81 | HRH3 (0.51) | FAAHHRH3CYP2D6HRH1MAOA | |
| SCHEMBL4622244 | 0.80 | ITGB3 (0.68) | ITGB3ITGA2BFFAR1FAAHRXRA | |
| SCHEMBL4045668 | 0.80 | MAOA (0.52) | FAAHHRH3CYP2D6HRH1MAOA | |
| SCHEMBL14263757 | 0.80 | MAOA (0.52) | FAAHHRH3CYP2D6HRH1MAOA | |
| SCHEMBL7303640 | 0.79 | ITGB3 (0.70) | ITGB3ITGA2BFFAR1RXRARXRB | |
| SCHEMBL4623073 | 0.79 | ITGB3 (0.74) | ITGB3ITGA2BFFAR1FAAHRXRA | |
| SCHEMBL12472053 | 0.79 | FAAH (0.59) | FAAHHRH3 | |
| SCHEMBL10226240 | 0.79 | CYP19A1 (0.54) | ITGB3ITGA2BFFAR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-5750524-A | ADMINISTERING AN SULFAMIDE SUBSTITUTED INDAN DERIVATIVE | ZERIA PHARMACEUTICAL CO., LTD. (JP) | 1998-05-12 | — | — | US | disclosed |
| EP-0773019-A1 | HYPERLIPEMIA REMEDY | ZERIA PHARMACEUTICAL CO., LTD. (JP) | 1997-05-14 | — | — | EP | disclosed |
| EP-0589037-B1 | INDIAN DERIVATIVE AND THROMBOXANE ANTAGONIST CONTAINING THE SAME | ZERIA PHARM CO LTD (JP) | 1996-05-29 | — | — | EP | disclosed |
| US-5409956-A | A sulfonylaminoalkylindan carboxylic acid or ester for treating thrombosis, vasospasm or asthma | ZERIA PHARMACEUTICAL CO., LTD. (JP) | 1995-04-25 | — | — | US | disclosed |
| EP-0589037-A1 | INDIAN DERIVATIVE AND THROMBOXANE ANTAGONIST CONTAINING THE SAME | ZERIA PHARMACEUTICAL CO., LTD. (JP) | 1994-03-30 | — | — | EP | disclosed |